Covered recipient · General Payments record
GISELA L MUNNE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,305.70
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $295.24 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $110.05 | 5 |
| Novo Nordisk AS | $93.73 | 6 |
| Exact Sciences Corporation | $46.16 | 2 |
| GlaxoSmithKline, LLC. | $30.66 | 2 |
| Acerta Pharma LLC | $14.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $14.64 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104487520 | CMS |
| Exact Sciences Corporation | $25.54 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114800900 | CMS |
| Exact Sciences Corporation | $20.62 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114800906 | CMS |
| GlaxoSmithKline, LLC. | $13.73 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115753390 | CMS |
| GlaxoSmithKline, LLC. | $16.93 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116618201 | CMS |
| Lilly USA, LLC | $18.80 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987574 | CMS |
| Lilly USA, LLC | $20.84 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134978328 | CMS |
| Lilly USA, LLC | $25.25 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134987910 | CMS |
| Lilly USA, LLC | $21.09 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134988866 | CMS |
| Lilly USA, LLC | $24.07 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135003829 | CMS |
| Novo Nordisk Inc | $13.77 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096968406 | CMS |
| Novo Nordisk Inc | $16.79 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096589596 | CMS |
| Novo Nordisk Inc | $14.35 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097062447 | CMS |
| Novo Nordisk Inc | $16.68 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096770096 | CMS |
| Novo Nordisk Inc | $16.68 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096939113 | CMS |
| Novo Nordisk Inc | $15.46 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096984656 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.